Best Kinase Inhibitor for lymphangioleiomyomatosis
The 4 Kinase Inhibitor options we list for lymphangioleiomyomatosis are all Sirolimus— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for lymphangioleiomyomatosis or the full Kinase Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 4 kinase inhibitor drugs we rate for lymphangioleiomyomatosis, all are available as lower-cost generics, and most are solution. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for lymphangioleiomyomatosis; the right choice depends on your situation, so confirm it with your prescriber.
How kinase inhibitor work
Kinase inhibitors block protein kinases, the enzymes that relay 'grow and divide' signals inside cells. By shutting down the overactive kinase signals that a tumor depends on, they help slow or stop cancer cells from multiplying.
Source: Tyrosine Kinase Inhibitors - StatPearls - NCBI Bookshelf
These are all Sirolimusin different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 4 kinase inhibitor products
sirolimus
Boxed warningPrescriptionFDA-sourced
Sirolimus is a kinase inhibitor used to treat Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms.
Pharmacy pays
From ~$33.55/30· 4 forms Save up to 47% in classfyarro
PrescriptionFDA-sourced
Fyarro (Sirolimus) is a kinase inhibitor used to treat Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms.
Pharmacy pays
From ~$33.55/30· 4 forms Save up to 47% in classhyftor
PrescriptionFDA-sourced
Hyftor (Sirolimus) is a kinase inhibitor used to treat Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms.
Pharmacy pays
From ~$33.55/30· 4 forms Save up to 47% in classrapamune
Boxed warningPrescriptionFDA-sourced
Rapamune (Sirolimus) is a kinase inhibitor used to treat Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms.
Pharmacy pays
From ~$33.55/30· 4 forms Save up to 47% in classFrequently asked
- What is the best kinase inhibitor for lymphangioleiomyomatosis?
- The Kinase Inhibitor options we list for lymphangioleiomyomatosis are all Sirolimus — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which kinase inhibitor drugs treat lymphangioleiomyomatosis?
- pharmaranks lists 4 Kinase Inhibitor products used for lymphangioleiomyomatosis, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.